Giunta A - Search Results

1

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.

Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Colombo C, et al. Among authors: giunta a. Hepatology. 1992 Apr;15(4):677-84. doi: 10.1002/hep.1840150421. Hepatology. 1992. PMID: 1551646

2

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome.

Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, Giunta A. Colombo C, et al. Among authors: giunta a. Hepatology. 2002 Dec;36(6):1374-82. doi: 10.1053/jhep.2002.37136. Hepatology. 2002. PMID: 12447862

3

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Among authors: giunta a. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

4

Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.

Colombo C, Battezzati PM, Crosignani A, Assaisso M, Ronchi M, Giunta A. Colombo C, et al. Among authors: giunta a. Acta Univ Carol Med (Praha). 1990;36(1-4):148-51. Acta Univ Carol Med (Praha). 1990. PMID: 2130679

5

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Colombo C, et al. Among authors: giunta a. J Pediatr. 1990 Sep;117(3):482-9. doi: 10.1016/s0022-3476(05)81103-5. J Pediatr. 1990. PMID: 2391610

6

Analysis of risk factors for the development of liver disease associated with cystic fibrosis.

Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, Sereni LP. Colombo C, et al. Among authors: giunta a. J Pediatr. 1994 Mar;124(3):393-9. doi: 10.1016/s0022-3476(94)70361-2. J Pediatr. 1994. PMID: 8120708

7

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.

Colombo C, Bertolini E, Assaisso ML, Bettinardi N, Giunta A, Podda M. Colombo C, et al. Among authors: giunta a. Acta Paediatr. 1993 Jun-Jul;82(6-7):562-5. doi: 10.1111/j.1651-2227.1993.tb12754.x. Acta Paediatr. 1993. PMID: 8338990

8

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.

Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Colombo C, et al. Among authors: giunta a. Hepatology. 1996 Jun;23(6):1484-90. doi: 10.1002/hep.510230627. Hepatology. 1996. PMID: 8675168 Clinical Trial.

9

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.

Colombo C, Crosignani A, Battezzati PM, Castellani MR, Comi S, Melzi ML, Giunta A. Colombo C, et al. Among authors: giunta a. J Hepatol. 1999 Oct;31(4):672-7. doi: 10.1016/s0168-8278(99)80347-x. J Hepatol. 1999. PMID: 10551391

10

Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis.

Colombo C, Arlati S, Curcio L, Maiavacca R, Garatti M, Ronchi M, Corbetta C, Giunta A. Colombo C, et al. Among authors: giunta a. Scand J Gastroenterol Suppl. 1988;143:151-6. doi: 10.3109/00365528809090237. Scand J Gastroenterol Suppl. 1988. PMID: 3164502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters